Cytokines upregulate vascular endothelial growth factor secretion by human airway smooth muscle cells: Role of endogenous prostanoids

FEBS Lett. 2005 May 9;579(12):2551-6. doi: 10.1016/j.febslet.2005.02.083. Epub 2005 Apr 7.

Abstract

Here, we report that vascular endothelial growth factor (VEGF)-A secretion by human airway smooth muscle cells was increased by interleukin 1 beta (IL-1beta) and transforming growth factor beta (TGFbeta). IL-1beta and TGFbeta induced cyclo-oxygenase (COX)-2 protein and increased prostaglandin E(2) (PGE(2)). Both IL-1beta and TGFbeta increased VEGF-A(165) mRNA and VEGF promoter luciferase construct activity, in addition VEGF-A protein was inhibited by actinomycin D suggesting transcriptional regulation. The COX inhibitors indomethacin and NS398 inhibited IL-1beta but not TGFbeta mediated VEGF-A production. Furthermore, the effect of the COX inhibitors was overcome by adding exogenous PGE(2). In conclusion, IL-1beta increases VEGF-A secretion by COX-2 derived PGE(2) production whereas TGFbeta uses COX-independent pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / pharmacology
  • Cytokines / antagonists & inhibitors*
  • Cytokines / pharmacology
  • Dactinomycin / pharmacology
  • Dinoprostone / biosynthesis*
  • Dose-Response Relationship, Drug
  • Enzyme Induction
  • Humans
  • Indomethacin / pharmacology
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / pharmacology
  • Kinetics
  • Luciferases / metabolism
  • Membrane Proteins
  • Muscle, Smooth / cytology
  • Muscle, Smooth / drug effects*
  • Muscle, Smooth / enzymology
  • Nitrobenzenes / pharmacology
  • Prostaglandin-Endoperoxide Synthases / biosynthesis*
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Sulfonamides / pharmacology
  • Trachea / cytology
  • Trachea / drug effects*
  • Trachea / enzymology
  • Transforming Growth Factor beta / pharmacology
  • Up-Regulation / drug effects*
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Cytokines
  • Interleukin-1
  • Membrane Proteins
  • Nitrobenzenes
  • RNA, Messenger
  • Sulfonamides
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factor A
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Dactinomycin
  • Luciferases
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone
  • Indomethacin